β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 4, 2015-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aspirin, beta-blocker and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

By Berger A.K.   Duval S.   Krumholz H.M.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 17-17

Elsevier

Access to resources Recommend Favorite

Beta Blocker Therapy After Acute Myocardial Infarction in Patients with Heart Failure and Systolic Dysfunction: Special Issue: An Overview of Beta-Blockers and Heart Failure (Guest Editor: Syed M. Jafri)

By Thattassery Emil   Gheorghiade Mihai  

Heart Failure Reviews, Vol. 9, Iss. 2, 2004-04 ,pp. : 107-113

Springer Publishing Company

Access to resources Recommend Favorite

Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?

By  

Current Cardiology Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 77-84

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombolytic Therapy Preserves Vagal Activity Early after Acute Myocardial Infarction

By Lind Pernille   Hintze Ulrik   Møller Mogens   Mickley Hans  

Scandinavian Cardiovascular Journal, Vol. 35, Iss. 2, 2001-03 ,pp. : 92-95

Informa Healthcare

Access to resources Recommend Favorite